Newsletter | October 2025 | | In 2025, the PhRMA Foundation (PhF) is celebrating our 60th anniversary. Since our founding in 1965, we have awarded more than $100 million in grants to over 2,700 researchers at hundreds of U.S. universities and institutions. | |
Inside Higher Ed’s Fight to Continue Groundbreaking Research in the Face of Funding Cuts
In this Fast Company article on the recent federal cuts to research funding, PhRMA Foundation President Dr. Amy M. Miller shares her perspective:
“There’s a lot of creativity going on right now,” Miller said. “But I really want to emphasize there is absolutely no way that the foundations and industry together can fill the gaps.”
Read the article.
| |
Apply: 2026 Awards in Value Assessment and Health Outcomes Research | | |
| |
The PhRMA Foundation seeks proposals from early career researchers who investigate challenges and potential solutions related to evaluating the delivery, safe use, effectiveness, and value (clinical, patient-centered, and economic) of drugs and other health care interventions.
Proposals should incorporate patient engagement at an appropriate level. Proposals that do not engage patients, caregivers, or clinicians will be considered unresponsive.
Deadline: October 30 @ 12:00 p.m. (Noon) ET
| | |
Watch: Engaging Patients in Research
This webinar focuses on why and how researchers should engage patients in value assessment and health outcomes research. Review committee members, a past awardee, and a patient advocate discuss ways that applicants can demonstrate their commitment to patient-centered research in their proposal.
| | | Frontier Award Study Empowers Patients to Confidently Engage in Value Assessment Research | | Dr. Surachat “Chat” Ngorsuraches of Auburn University is prioritizing authentic patient engagement throughout the research process in his Foundation-funded study on how patients and caregivers in the Deep South value therapies for multiple sclerosis. Read more. | | | |
A Smart Boot and Digital Monitoring Platform to Improve Wound Healing for Diabetic Foot Ulcer
Dr. David G. Armstrong of the University of Southern California has dedicated his career to caring for people’s feet. His Foundation-funded research focuses on helping patients better manage diabetic foot ulcers using digital health technologies to enhance limb preservation and reduce health disparities for disadvantaged populations. Learn more.
| | Hear directly from our 2025 award recipients about their research and career paths. | | Annalisa Ferrotta: Understanding Glioblastoma Treatment Failures and Evaluating New Options | | Tim Lai: Leveraging Real-World Data and Patient Preferences to Improve Depression Treatment | | Dr. Yu-Hsiang Chen: Tracking Residual Cancer Cells After Treatment to Prevent Relapse | | Dr. Lisa Volpatti: Turning Bad Cholesterol Into a Good Drug Delivery Vehicle | | |
Congrats to these Foundation-funded researchers on their recent work.
**Indicates research directly supported by a PhRMA Foundation award.
| | David G. Armstrong, DPM, MD, PhD (PhF24) of the University of Southern California gave the keynote address at the Mexican Wound Healing Society meeting this month, sharing work supported by his Foundation grant. | | David Barthold, PhD (PhF21) of the University of Washington gave a research presentation titled "Modifiable risk factors for dementia: potential for prevention" at the annual meeting of the Congressional Budget Office Panel of Health Advisers in September. | | Emilie Duchesneau, PhD (PhF24) of Wake Forest University and her team presented two posters about her Foundation-funded research at the 2025 Annual Meeting of the International Society for Pharmacoepidemiology (ISPE) in August in Washington, DC. | Claire Fleming, MS (PhF25) of the University of Virginia was selected for an NIH F31 Predoctoral Fellowship. She was also awarded for her poster presentation at the Lung Development, Injury & Repair Gordon Research Conference. | Tamanna Islam, MSc (PhF24) of the University of Utah will give a podium presentation about her Foundation-funded work “Bioengineered Approach to Study Cell-specific Durotaxis in Lung Fibrosis and Pulmonary Arterial Hypertension” at BMES 2025 in San Diego this month. | Aakanksha Rajiv Kapoor (PhF23) of Weill Cornell Medicine gave a short talk on her Foundation-funded work at Frontiers in Cancer Immunotherapy by the New York Academy of Sciences in June. | Ariel Leyte-Vidal (PhF25) of the University of Miami will give an oral presentation on her Foundation-funded work this month at the ESH-iCMLf 27th Annual John Goldman Conference on Chronic Myeloid Leukemia: Biology and Therapy. | Na Li, PhD (PhF22) of the University of Connecticut received the 2025 Rising Star Scholarship Award from the National Institute for Pharmaceutical Technology and Education. | | Yongbin Liu, PhD (PhF23) of Houston Methodist Research Institute received his first R21 grant from NIH/NIAID. "I am truly grateful for the PhRMA Foundation’s support, which has been invaluable in helping me move forward in my research career," he said. | | |
Did someone forward this to you?
Subscribe to get updates and funding announcements directly in your inbox.
| | | | | |
